迪瑞醫療(300396.SZ):13項醫療器械產品取得CE認證證書
格隆匯 3 月 21日丨迪瑞醫療(300396.SZ)公佈,公司的13項醫療器械產品於近日取得了CE認證證書,具體情況如下:



上述產品屬於血細胞分析、生化分析領域,公司根據市場反饋,結合血細胞分析市場發展形勢,在維護升級現有產品的同時,不斷更新新產品,提高在血細胞分析技術領域的成熟性和可靠性,進一步推進公司相關產品在血細胞分析市場迅速發展。生化診斷是最早實現自動化的檢測手段,也是目前最常用的體外診斷方法之一。目前,醫療衞生機構是消費生化試劑產品的主力軍。
上述產品取得CE認證證書,表明了該產品符合歐盟相關要求,已經具備歐盟市場的准入條件,將進一步增強公司產品的綜合競爭力,對公司未來的經營將產生積極影響。上述產品實際銷售情況取決於未來市場推廣效果,公司目前尚無法預測其對公司未來業績的影響,敬請投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.